Byrne Financial Freedom’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$244K Sell
497
-1,008
-67% -$547K 0.12% 93
2025
Q4
$872K Buy
1,505
+110
+8% +$62.2K 0.4% 46
2025
Q3
$677K Sell
1,395
-16
-1% -$7.45K 0.34% 49
2025
Q2
$572K Sell
1,411
-555
-28% -$232K 0.29% 55
2025
Q1
$978K Sell
1,966
-120
-6% -$65K 0.56% 40
2024
Q4
$1.08M Buy
+2,086
New +$1.15M 0.48% 43

Other funds holding TMO

Byrne Financial Freedom's TMO Position: Q1 2026 in Review

Byrne Financial Freedom reduced its Thermo Fisher Scientific (TMO) stake by 67% in Q1 2026, selling an estimated $547K and leaving 497 shares worth $244K. The position accounts for 0.12% of the portfolio, ranked #93.

Byrne Financial Freedom first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.08M in Q4 2024. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Byrne Financial Freedom held 497 shares of Thermo Fisher Scientific worth $244K as of Q1 2026.
  • Byrne Financial Freedom sold 1,008 Thermo Fisher Scientific shares in Q1 2026, an estimated $547K.
  • Thermo Fisher Scientific made up 0.12% of Byrne Financial Freedom's portfolio in Q1 2026, its #93 holding.
  • Byrne Financial Freedom first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Byrne Financial Freedom's Thermo Fisher Scientific position peaked at $1.08M in Q4 2024.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Byrne Financial Freedom's 13F filing for Q1 2026, filed 27 Apr 2026.